Glomangioma of the trachea: A case report and literature review

  • Authors:
    • Yang Tan
    • Peng Yang
    • Xiaoyu Deng
    • Yan Tang
  • View Affiliations

  • Published online on: January 13, 2015     https://doi.org/10.3892/ol.2015.2871
  • Pages: 1273-1277
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A 44‑year‑old male presented with progressing cough, dyspnea and hemoptysis due to a tracheal tumor involving the posterior wall of the lower trachea, with severe airway obstruction and coagulopathy. Consequently the patient underwent segmental resection of the trachea with an end‑to‑end anastomosis. Twenty months after treatment there remained no evidence of endobronchial recurrence at bronchoscopy or imaging studies. The diagnosis was benign tracheal glomus tumor (GT) which is an exceedingly rare mass lesion in the trachea. There are three subtypes: GT proper, glomangioma and glomangiomyoma. The present study describes the clinical and pathological features of glomangioma through a case report and literature review. To the best of our knowledge, this is the fifth report of glomangioma subtype arising from the trachea.

Introduction

Glomus tumors (GTs) are neoplasms arising from the modified smooth muscle cells surrounding arteriovenous anastomosis (1,2). GT is an uncommon soft tissue tumor with an incidence of 1.6%, which is usually located in the dermis and subcutaneous tissue, with ≤65% occurring in the subungual area. Due to sparse or absent glomus bodies in the visceral organs, extracutaneous presentation of GT is rarely observed (38). Previously reported atypical sites of origin include the stomach, mediastinum, vagina, penis, lung, patella and trachea. Histologically, GTs have been divided into three subtypes: Classic glomus tumors, glomangiomas, and glomangiomyomas. Glomangiomas are an uncommon type, accounting for <20% of GTs (1,2,911). Until now, only 27 cases of GTs, and five reports of glomangioma subtype arising from the trachea, including the present case, have been reported (832). GTs are usually benign and recurrence rates are variable, ranging from 10 to 30% (1,2). The present study reported a primary GT of the trachea, which is a possible differential diagnostic alternative when a tracheal tumor is detected by radiographic or endoscopic examination. Written informed consent was obtained from the patient and the patient’s family.

Case report

A 44-year-old male, exhibiting a defined tracheal tumor that was diagnosed by the local hospital (Bazhou People’s Hospital, Bazhou, China) two months earlier, was admitted to our hospital (The Third People’s Hospital of Chengdu, Chengdu, China) due to acute respiratory distress. The patient had suffered from cough, expectoration and dyspnea without any evident incentive for >1 year. Six days before admission, the symptoms were aggravated with hemoptysis. A chest X-ray scan was found to be normal. However, a computed tomographic (CT) scan revealed a demarcated homogenous intratracheal mass at the layer of the superior border of the manubrium (Fig. 1). Flexible bronchoscopy revealed a sessile tumor with a smooth surface arising from the posterior wall of the trachea, which occluded ~90% of the trachea lumen, at 3 cm proximal to the carina. A biopsy was performed to elucidate the nature of the tumor. At 3 h after referral, the patient exhibited no response to voice and became signally dyspneic and cyanotic in the face and extremities, which indicated apnea induced by neoplastic obstruction.

To prevent mortality and restore the airway, endotracheal intubation was conducted initially using a rigid tracheoscope under surface anesthesia. Due to the unstable condition of the patient, comprehensive treatment was administered to prepare for the operation. A preoperative coagulation profile revealed prolonged activated partial thromboplastin time (APTT; 68.3 sec) and prothrombin time (PT; 19.1 sec), which indicated an increased risk for the surgery. With plasma transfusion, after five days the patient underwent segmental resection of the trachea with an end-to-end anastomosis and the bilateral pulmonary infection led to a poor general postoperative condition. Due to being bed-ridden postoperatively, 13 days following the surgery the patient exhibited femoral and deep vein thrombosis. Thrombolytic therapy was challenging, due to the persistent bleeding disorder. To prevent pulmonary embolus, vena cava filters were placed and clot-busting therapy was conducted simultaneously. The patient was discharged without the support of ventilation 26 days after presentation. Three months after resection, the patient underwent follow-up with CT and endoscopy to exclude focal recurrence or suspicious metastasis. The lumen of the trachea remained clear for 20 months after the surgery.

The surgical specimen was ~2 cm in length, with a luminal diameter of 2.5 cm. The specimen exhibited a 3×2.5×1 cm red-brown mass sessile in the posterior wall of the trachea, which occupied the lumen as a polypoid mass (Fig. 2). Microscopically, the tumor was composed of epithelioid round to polygonal cells with defined cellular borders, weakly eosinophilic or clear cytoplasm and uniform round to ovoid nuclei. These formed solid sheets, small nests or organoidal structures surrounding dilated and tangled venous vessels, which were different from the thin-walled and capillary-like vascular channels normally observed in GT proper type. Cellular atypia and mitotic figures were absent (Fig. 3A). Gomori’s staining demonstrated a delicate network of reticulum fibers lying between individual tumor cells (Fig. 3B). In addition, evidence of squamous metaplasia was observed in the intact overlying respiratory epithelium. Immunohistochemical staining revealed positivity for vimentin and smooth muscle actin antibodies (Fig. 3C). Pan-cytokeratin, desmin, chromogranin, synaptophysin, S-100, calfetinin, leukocyte common antigen, HMB-45 and cluster of differentiation 99 were negative (Table I). The tumor was diagnosed as a glomangioma.

Table I

Antibody panel used in this case study.

Table I

Antibody panel used in this case study.

Antibody/moleculeCloneDilutionExpression
SMA1A41:70(+)
VimentinSP201:70(+)
DesminD331:70(−)
Pan-cytokeratinAE1/AE31:70(−)
ChromograninSP121:70(−)
SynaptophysinSP111:70(−)
S-1004C4.91:70(−)
CalfetininPolyclone1:60(−)
LCAZB11+PD7/261:70(−)
MelanosomeHMB-451:70(−)
CD99SP1191:70(−)

[i] Antigen retrieval was PH9.0EDTA (microwave), and Zeta Corporation (Sierra Madre, CA, USA) provided the mouse anti-human monoclonal antibodies for the present study. (+), positive; (−), negative; CD99, cluster of differentiation 99; SMA, smooth muscle actin; LCA, leukocyte common antigen.

Discussion

GTs are uncommon mesenchymal neoplasms. The etiology of these tumors remains a conundrum, and certain individuals attribute GTs to trauma, endocrine disorder or autosomal dominant inheritance (1,2). Murray and Stout (2) indicated that GT often occurred in subungual hematoma and the fingertips of female patients, while in the extradigital tissues of male patients. This viewpoint coincides with previous studies on the tracheal GTs presented in Table II, in which the majority of cases involved male patients. GTs in the trachea are scarce. The first GT case was reported in 1950 and, to the best of our knowledge, since then only 27 additional cases (including the present study) have been reported (Table II) (832). Based on the literature reviewed (Table III), the majority of cases have been identified on the posterior wall of the lower two-thirds of the trachea (82%), where mucus glands and vessels are numerous. The cases included 16 males and 10 females (1.6:1), with a mean age of 50. The main symptoms included coughing, dyspnea and hemoptysis. Certain patients also suffered from chest pain, stridor and hoarseness. The mass diameter had a range of 1.2–4.5 cm. Almost all the tumors, including that of the present study, were benign and noninvasive.

Table II

Reported cases of tracheal glomus tumor.

Table II

Reported cases of tracheal glomus tumor.

First author, year (ref)Patient age/genderSymptomsSize (cm)Tracheal locationMain treatmentFollow-up
Hussarek, 1950 (8)43/FDyspnea‘Bean-sized’Upper tracheaTracheal resectionNot stated
Fabich, 1980 (9)63/MCough2.5×2×1Lower tracheaTracheal resectionSuccumbed to complications, postop day 10
Heard, 1982 (10)50/MAsthma-like symptoms2.5×1.5×1.0Lower tracheaTracheal resectionSepsis, died postop day 15
Ito, 1988 (11)51/MRespiratory infections, hemoptysis1.5×1.2×1.0Upper tracheaTracheal resectionNo recurrence at 2 years
Kim, 1989 (12)54/FCough, dyspnea, hemoptysis1.5×1.2Mid-tracheaTracheal resectionNo recurrence at 13 months
Shin, 1990 (13)47/FIntermittent cough and hemoptysis1.5×1.0×1.0Lower tracheaTracheal resectionNot stated
Garcia-Prats, 1991 (14)58/MDyspnea, cough, hemoptysis2.5×1.8Mid-tracheaTracheal resectionNo recurrence at 8 months
Haraguchi, 1991 (15)61/MAsymptomatic1.2Mid-tracheaTracheal resectionNot stated
Arapantoni, 1995 (16)65/MDyspnea, hemoptysis4.5×3Lower tracheaEndoscopic resection and Nd-YAGNo recurrence at 1 year
Koskinen, 1998 (17)66/MAsymptomatic3×2Lower tracheaEndoscopic resection, Nd-YAG, and external radiotherapyNot stated
Watanabe, 1998 (18)43/MHoarseness2.0×1.6×1.4Lower tracheaTracheal resectionNo recurrence at 20 months
Menaissy, 2000 (19)34/MHemoptysis2.4×2.1×1.6Mid-tracheaTracheal resectionNo recurrence at 4 months
Gowan, 2001 (20)73/MCough, hemoptysis, dyspnea, Chest pain1.6×0.6×0.3Mid-tracheaTracheal resectionNo recurrence at 6 years
Chien, 2003 (21)50/FCough, dyspnea, hemoptysis2.5×2.5×2Lower tracheaTracheal resectionNo recurrence at 1 years
Nadrous, 2004 (22)39/MIntermittent hemoptysis2.0×1.5×1.5Upper tracheaTracheal resectionNo recurrence at 3 months
Haver, 2008 (23)10/FDyspnea1.8×1.3×1.3Mid-tracheaTracheal resectionNo recurrence at 2 years
Colaut, 2008 (24)70/MDyspnea2×1×1Mid-tracheaEndoscopic resection and Nd-YAGNo recurrence at 2 years
Parker, 2010 (25)43/FChest pain, asthma2.0×1.6×1.5Lower tracheaTracheal resectionNot stated
Shang, 2010 (26)59/MChest pain, dyspnea2.0×1×0.5Lower tracheaEndoscopic resectionNo recurrence at 12 months
22/FCough, dyspnea1.8×1.5×1.4Lower tracheaEndoscopic resectionNo recurrence at 12 months
Sakr, 2011 (27)66/MDyspnea, stridor2×1.2×0.8Upper tracheaEndoscopic resection and tracheal resectionNo recurrence at 21 months
Mogi, 2011 (28)56/FCough, dyspnea1.3×1.2×1.1Lower tracheaTracheal sleeve resectionNo recurrence at 9 months
Okereke, 2011 (29)58/MStridor, shortness of breath.1.1Mid-tracheaTracheal resectionNot stated
Norder, 2012 (30)49/FCough, dyspnea1.2×1.1×1.1Upper tracheaEndoscopic resectionNot stated
Lang-Lazdunski L, 2012 (31)62/FCough, dyspnea1.6Lower tracheaLeft upper sleeve lobectomyNot stated
Fan, 2013 (32)15/MCough, hemoptysis2.5Lower tracheaTracheal resectionNo recurrence at 12 months
Present study44/MCough, hemoptysis, dyspnea3×2.5×1Lower tracheaTracheal resectionNo recurrence at 20 months

[i] F, female; M, male; Nd-YAG, neodymium-yttrium-aluminum-garnet laser; postop, postoperative.

Table III

Summary characteristics of previously reported patients with glomus tumor of the tracheaa.

Table III

Summary characteristics of previously reported patients with glomus tumor of the tracheaa.

CharacteristicValue
Age, range (mean)10–73 (50)
Male:Female1.6:1
Symptoms, n (%)b
 Cough11 (41)
 Hemoptysis11 (41)
 Dyspnea15 (56)
 Chest pain3 (11)
 Asthma or stridor3 (11)
 None2 (7)
Tumor size, range (mean)1.1–4.5 (2.06)
Tumor location, n (%)b
 Upper trachea5 (18%)
 Mid-trachea8 (30%)
 Lower trachea14 (52%)
Treatment, n
 Tracheal resection19
 Endoscopic resection7
 Other1

a Data were obtained from references 832.

b Certain patients presented multiple symptoms: Symptoms (%), number of patients with this symptom/total number of patients × 100; tumor location (%), number of patients in this location/total number of patients × 100.

To the best of our knowledge, no malignant GTs have been described in the trachea thus far. The histological morphology varies in subtypes according to the relative proportions of the glomus cells, vascular structures and smooth muscle tissue (2,33). In addition to the classic three subtypes, including GT proper, glomangioma and glomangiomyoma, an oncocytic variant exists that was first described in 1990 (13). GT proper type accounts for ~75% of all the GTs, which also applies to the tracheal mass, while glomangioma occupies 20% of all the cases (Table II). The oncocytic tumors are the least common, comprising 1/20 of all the tracheal GTs reported in the literature (13). In the present study, the tumor was characterized by organoid nests and solid sheets of uniform round or polygonal cells around the venous vessels, but not thin-walled or capillary-like vascular channels. This is the fifth description of a glomangioma arising from the trachea. In the study by Shin et al, the round glomus cells represented the largest component of tumor cells surrounding the thin-walled vascular spaces, leading to the hypothesis that this may be a subtype of glomangioma (13). Based on the Pathology and Genetics of Tumors of Soft Tissue and Bone (World Health Organization Classification of Tumors), the main histological characteristic of glomangioma is that the glomus cell clusters are arranged around dilated venous vessels (33). The immunohistochemical features have contributed to differential diagnosis with carcinoid and hemangiopericytoma (28,32,33). GTs are positive for vimentin and smooth musle actin, but negative for neuroendocrine and epithelial markers, including S-100 protein, chromogranin, desmin, cytokeratins and factor VIII.

To avoid local recurrence, tracheal resection is widely used and exhibits favorable prognosis (Table II). Endoscopic intervention alone is also applied in a limited number of cases, which has rigorous indications if: The lesion is strictly confined without extension; histology confirms the tumor is benign; as a temporary measure for surgery preparation; or the patient is not fit or willing to undergo surgical resection. In addition, interventional bronchoscopy is a first-line treatment to immediately restore the airway patency in urgent situations (14,16,17, 2527,30).

Furthermore, as an uncommon site, treating the complications and accompanying diseases during the perioperative period is crucial in order to increase survival rates. The main cause of mortality reported in the literature following surgery was not the primary tumor or the procedure but the complications (9,10). The present patient exhibited a severe clinical condition and the symptoms were caused by tumor obstruction. Therefore, endotracheal intubation was performed to aid the recovery of the stabilization, ensuring that the patient fit for the procedure. Due to his severe coagulopathy, preoperative correction of coagulation disturbance was performed to prepare for the surgery. The filters of the vena cava and warfarin administration were arranged simultaneously following surgery to treat femoral and deep vein thrombosis caused by a long time period in bed. Active sputum excretion, prevention of infections and early mobilization is beneficial for recovery.

In conclusion, previous studies and the present report reveal that the incidence of GTs in the trachea is low and these tumors primarily occur in males, with unknown etiology and concealed onset. Patients with GTs usually resort to medical attention for symptoms of airway obstruction. CT imaging, magnetic resonance imaging and flexible bronchoscopy of GTs reveal a lumen-occupying lesion. Surgical management is generally the primary option and histopathological examination may determine the diagnosis. The long-term prognosis of the disease is promising.

References

1 

Enzinger FM, Weiss SW and Chandrasekhar B: Soft tissue tumors. PRS Journal. 76:153–155. 1985.

2 

Murray MR and Stout AP: The glomus tumor: Investigation of its distribution and behavior, and the identity of its ‘epithelioid’ cell. Am J Pathol. 18:183–203. 1942.PubMed/NCBI

3 

Kanwar YS and Manaligod JR: Glomus tumor of the stomach. An ultrastructural study. Arch Pathol. 99:392–397. 1975.PubMed/NCBI

4 

Brindley GV Jr: Glomus tumor ofthe mediastinum. J Thorac Surg. 18:417–420. 1949.PubMed/NCBI

5 

Banner EA and Winkelmann RK: Glomus tumor of the vagina; report of a case. Obstet Gynecol. 9:326–328. 1957.PubMed/NCBI

6 

Graner BC and Burt JC: Unusual location of glomus tumor: report of two cases. JAMA. 112:1806–1810. 1939. View Article : Google Scholar

7 

Tang CK, Toker C, Foris NP and Trump BF: Glomangioma of the lung. Am J Surg Pathol. 2:103–109. 1978. View Article : Google Scholar : PubMed/NCBI

8 

Hussarek M and Rieder W: Glomus tumor of the trachea. Krebsarzt. 5:208–212. 1950.(In Undetermined Language). PubMed/NCBI

9 

Fabich DR and Hafez GR: Glomangioma of the trachea. Cancer. 45:2337–2341. 1980. View Article : Google Scholar : PubMed/NCBI

10 

Heard B E, Dewar A, Firmin R K, et al: One very rare and one new tracheal tumour found by electron microscopy: glomus tumour and acinic cell tumour resembling carcinoid tumours by light microscopy. Thorax. 37:97–103. 1982. View Article : Google Scholar : PubMed/NCBI

11 

Ito H, Motohiro K, Nomura S, et al: Glomus tumor of the trachea: immunohistochemical and electron microscopic studies. Pathology-Research and Practice. 183:778–782. 1988. View Article : Google Scholar

12 

Kim Y I, Kim J H, Suh J S, et al: Glomus tumor of the trachea. Report of a case with ultrastructural observation. Cancer. 64:881–886. 1989. View Article : Google Scholar : PubMed/NCBI

13 

Shin DH, Park SS, Lee JH, et al: Oncocytic glomus tumor of the trachea. Chest. 98:1021–1023. 1990. View Article : Google Scholar : PubMed/NCBI

14 

García-Prats MD, Sotelo-Rodríguez MT, Ballestín C, et al: Glomus tumour of the trachea: report of a case with microscopic, ultrastructural and immunohistochemical examination and review of the literature. Histopathology. 19:459–464. 1991. View Article : Google Scholar : PubMed/NCBI

15 

Haraguchi S, Yamamoto M and Nishimura H: A glomus tumor of the trachea - a case report. Nihon Kyōbu Geka Gakkai. 39:214–218. 1991.

16 

Arapantoni-Dadioti P, Panayiotides J, Fatsis M and Antypas G: Tracheal glomus tumour. Respiration. 62:160–162. 1995. View Article : Google Scholar : PubMed/NCBI

17 

Koskinen SK, Niemi PT, Ekfors TO, et al: Glomus tumor of the trachea. Eur J Radiol. 8:364–366. 1998. View Article : Google Scholar

18 

Watanabe M, Takagi K, Ono K, et al: Successful resection of a glomus tumor arising from the lower trachea: report of a case. Surg Today. 28:332–334. 1998. View Article : Google Scholar : PubMed/NCBI

19 

Menaissy YM, Gal AA and Mansour KA: Glomus tumor of the trachea. Ann Thorac Surg. 70:295–297. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Gowan RT, Shamji FM, Perkins DG and Mazaik DE: Glomus tumor of the trachea. Ann Thorac Surg. 72:598–600. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Chien ST, Lee TM, Hsu JY, et al: Glomus tumor of the trachea. J Chin Med Assoc. 66:551–554. 2003.PubMed/NCBI

22 

Nadrous HF, Allen MS, Bartholmai BJ, et al: Glomus tumor of the trachea: value of multidetector computed tomographic virtual bronchoscopy. Mayo Clin Proc. 79:237–240. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Haver KE, Hartnick CJ, Ryan DP, et al: Case records of the Massachusetts General Hospital. Case 10-2008 A 10-year-old girl with dyspnea on exertion. N Engl J Med. 358:1382–1390. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Colaut F, Toniolo L, Scapinello A and Pozzobon M: Tracheal glomus tumor successfully resected with rigid bronchoscopy: a case report. J Thorac Oncol. 3:1065–1067. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Parker KL, Zervos MD, Donington JS, et al: Tracheal glomangioma in a patient with asthma and chest pain. J Clin Oncol. 28:e9–e10. 2010. View Article : Google Scholar

26 

Shang Y, Huang Y, Huang HD, et al: Removal of glomus tumor in the lower tracheal segment with a flexible bronchoscope: report of two cases. Intern Med. 49:865–869. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Sakr L, Palaniappan R, Payan MJ, et al: Tracheal glomus tumor: a multidisciplinary approach to management. Respir Care. 56:342–346. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Mogi A, Kosaka T, Yamaki E, et al: Successful resection of a glomus tumor of the trachea. Gen Thorac Cardiovasc Surg. 59:815–818. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Okereke IC, Sheski FD and Cummings OW: Glomus tumor of the trachea. J Thorac Oncol. 6:1290–1291. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Norder E, Kynyk J, Schmitt AC, et al: Glomus tumor of the trachea. J Bronchology Interv Pulmonol. 19:220–223. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Lang-Lazdunski L, Bille A, Cane P and Congleton J: Glomus tumour: a rare differential diagnosis of bronchial obstruction in a smoker. Gen Thorac Cardiovasc Surg. 60:774–776. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Fan M, Liu C, Mei J, et al: A rare large tracheal glomus tumor with postoperative haematemesis. J Thorac Dis. 5:E185–E188. 2013.PubMed/NCBI

33 

Kleihues P and Sobin LH: World Health Organization classification of tumors. Cancer. 88:28872000. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

March-2015
Volume 9 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tan Y, Yang P, Deng X and Tang Y: Glomangioma of the trachea: A case report and literature review. Oncol Lett 9: 1273-1277, 2015
APA
Tan, Y., Yang, P., Deng, X., & Tang, Y. (2015). Glomangioma of the trachea: A case report and literature review. Oncology Letters, 9, 1273-1277. https://doi.org/10.3892/ol.2015.2871
MLA
Tan, Y., Yang, P., Deng, X., Tang, Y."Glomangioma of the trachea: A case report and literature review". Oncology Letters 9.3 (2015): 1273-1277.
Chicago
Tan, Y., Yang, P., Deng, X., Tang, Y."Glomangioma of the trachea: A case report and literature review". Oncology Letters 9, no. 3 (2015): 1273-1277. https://doi.org/10.3892/ol.2015.2871